Essential Reads: The Use of Trazodone During Pregnancy
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
These findings are encouraging and suggest that the newer AEDs, specifically lamotrigine and levetiracetam, are not associated with worse neurodevelopmental outcomes.
While questions and controversies remain, the information on long-term neurodevelopmental outcomes in children prenatally exposed to antidepressants is largely reassuring.
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
Every week we review the most recent publications in women’s mental health.
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
Lamotrigine is detected in the breast milk and in the serum of the nursing infant; however, the risk of adverse events is very low.
The FDA will review zuranolone for the treatment of depression in the first half of 2022.
Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.
Given limited data on the reproductive safety of oxcarbazepine, we would recommend using alternate medications during pregnancy, when possible.Â